Abstract Oral squamous cell carcinoma (OSCC), the most commonly diagnosed oral cancer, has a poor prognosis, especially in the advanced stages. Chemerin, an adipokine that plays a significant role in inflammation and adipogenesis, has emerged as a prognostic biomarker in OSCC. The study evaluates immunohistochemical expression of chemerin and CD34-assessed microvessel density, and investigates their association with clinicopathological parameters and disease-free survival (DFS) in OSCC patients.
Mary Mathew
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Mary
Contact Mary, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack